Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study-Reference-Cited by-同舟云学术

Progression of subclinical atherosclerosis in ankylosing spondylitis: a 10-year prospective study

Published:2024-02-13 Issue:4 Volume:44 Page:643-652
ISSN:1437-160X
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Arida Aikaterini^ORCID,Fragoulis George E.^ORCID,Terentes-Printzios Dimitrios^ORCID,Konstantonis George,Protogerou Athanasios D.^ORCID,Vlachopoulos Charalambos^ORCID,Tektonidou Maria^ORCID,Sfikakis Petros P.^ORCID

Funder

National Center for Special Education Research, Institute of Education Sciences

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s00296-023-05528-7.pdf

Reference39 articles.

1. Arida A, Protogerou AD, Kitas GD, Sfikakis PP (2018) Systemic inflammatory response and atherosclerosis: the paradigm of chronic inflammatory rheumatic diseases. Int J Mol Sci. https://doi.org/10.3390/ijms19071890

2. Drosos GC, Vedder D, Houben E et al (2022) EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome. Ann Rheum Dis. https://doi.org/10.1136/ANNRHEUMDIS-2021-221733

3. Agca R, Heslinga SC, Rollefstad S et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76:17–28. https://doi.org/10.1136/annrheumdis-2016-209775

4. Zhao SS, Robertson S, Reich T et al (2020) Prevalence and impact of comorbidities in axial spondyloarthritis: systematic review and meta-analysis. Rheumatology. https://doi.org/10.1093/rheumatology/keaa246

5. Hintenberger R, Affenzeller B, Vladychuk V, Pieringer H (2023) Cardiovascular risk in axial spondyloarthritis-a systematic review. Clin Rheumatol. https://doi.org/10.1007/S10067-023-06655-Z